Biomarcadors d'imatge multimodal
Publicacions destacades
-
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Giné, E; de la Cruz, F; Ubieto, AJ; Jimenez, JL; García-Sancho, AM;(...)Sanz, RG; Nadeu, F; Beà, S; Campo, E; López-Guillermo, A.Referència:Journal Of Clinical Oncology 2022.
-
Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [<sup>18</sup>F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125
Glickman, Ariel; Paredes, Pilar; Carreras-Dieguez, Nuria; Ninerola-Baizan, Aida; Gaba, Lydia;(...)Romero, Inmaculada; Fernandez-Galan, Esther; Carrasco, Josep Lluis; Gil-Ibanez, Blanca; Torne, Aureli.Referència:European Radiology 2022.
-
Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines
Canals, J; Navarro, A; Vila, C; Canals, JM; Díaz, T;Acosta-Plasencia, M; Cros-Font, C; Han, B; He, YY; Monzó, M.Referència:Journal Of Experimental & Clinical Cancer Research 2022.
-
Role of a portable gamma-camera with optical view for margins assessment of pulmonary nodules resected by radioguided surgery
Vollmer, I; Sánchez-Izquierdo, N; Martínez, D; Sánchez-Lorente, D; Casanueva-Eliceiry, S;Boada, M; Guirao, A; Romero-Zayas, I; Vidal-Sicart, S; Paredes, P.Referència:European Journal Of Nuclear Medicine And Molecular Imaging 2021.
-
Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients
de Aledo-Castillo, JMG; Casanueva-Eliceiry, S; Soler-Perromat, A; Fuster, D; Pastor, V;(...)Viñolas, N; Reyes, R; Vollmer, I; Paredes, P; Puig-Butillé, JA.Referència:European Journal Of Nuclear Medicine And Molecular Imaging 2021.
-
Sentinel Lymph Node Biopsy in Breast Cancer with 99mTc-Tilmanocept: A Multicenter Study on Real-Life Use of a Novel Tracer
Vidal-Sicart, S; Rioja, ME; Prieto, A; Goñi, E; Gómez, I;Albala, MD; Lumbreras, L; León, LF; Gómez, JR; Campos, F.Referència:Journal Of Nuclear Medicine 2021.
-
PET/CT Integrated With CT Colonography in Preoperative Obstructive Colorectal Cancer by Incomplete Optical Colonoscopy A Prospective Study
Sanchez-Izquierdo, Nuria; Pages, Mario; Mayoral, Maria; Rubello, Domenico; Colletti, Patrick M.;Campos, Francisco; Romero, Inmaculada; Casanueva, Sebastian; Fritsch, Andrea; Fuster, David;.Referència:Clinical Nuclear Medicine 2020.
-
Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma
Sanchez-Izquierdo, Nuria; Perlaza, Pilar; Pages, Mario; Buxo, Elvira; Rios, Jose;(...)Mayoral, Maria; Casanueva, Sebastian; Fernandez-Esparrach, Gloria; Gines, Angels; Fuster, David.Referència:Clinical Nuclear Medicine 2020.
-
Diagnostic accuracy of imaging studies for initial staging of T2b-T4b melanoma patients
Riquelme-Mc Loughlin, Constanza; Podlipnik, Sebastian; Bosch-Amate, Xavier; Riera-Monroig, Jose; Barreiro, Alicia;(...)Sanchez, Marcelo; Vidal-Sicart, Sergi; Carrera, Cristina; Malvehy, Josep; Puig, Susana.Referència:Journal Of The American Academy Of Dermatology 2019.
-
Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G;(...)Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D .Referència:Clinical Nuclear Medicine 2018.